Übersicht

Richard Smith is a partner in the Corporate & Securities practice of the London office. "Recommended" in Legal 500 2014, he advises on a wide range of corporate transactions, including company and business sales/purchases, initial public offerings, joint ventures, private equity investments, and corporate reconstructions.

Sprachkenntnisse

  • Englisch

Erfahrung

  • Advising Syngenta on the sale of Syngenta Bioline Ltd to Union InVivo.
  • Advising Universal Coal plc on A$24.5 million strategic investment by IchorCoal.
  • Advising Adaptimmune Ltd on $104 million Series A financing.
  • Advising Imperial Innovations Group plc on equity raising of £150 million by way of placing of ordinary shares.
  • Advising GW Pharmaceuticals plc on US public offering of ADSs totalling $169.8 million.
  • Advising GW Pharmaceuticals plc on follow-on offering of ADSs raising $101.1 million on Nasdaq.
  • Advising GW Pharmaceuticals plc on its initial public offering on Nasdaq.
  • Advising Elsevier on the sale of its UK science and technology division books list to Informa.
  • Advising Content Ventures Ltd on the introduction of a new Luxembourg holding company by way of scheme of arrangement.
  • Advising Imperial Innovations Group plc on equity raising of £140 million by way of rights issue of ordinary shares and issue of warrants to subscribe for class of partly paid convertible shares.
  • Advising Haas TCM on the acquisition of Aeropia and RD Taylor & Company from Umeco plc.
  • Advising Rhodia on the sale of its European specialty phosphates business to Thermphos International.
  • Advising Rhodia on the sale of its polyurethane flame retardants business to Albermarle Corporation.
  • Advising Apace Media plc on the sale of 50% of Balkan Media Group to MTG Broadcasting AB.
  • Advising Vue Entertainment on the acquisition of the Warner Village cinema circuit.
  • Advising Vue Entertainment on the acquisition of the Ster Century UK cinema circuit.
  • Advising Infrastructure India plc on its establishment and admission to the Official List of the UK Listing Authority.
  • Advising Imperial Innovations Group plc on its admission to AIM.
  • Advising Worldwide Clinical Trials on the acquisition of Nottingham Clinical Research.

Veröffentlichungen

Ausbildung

The College of Law, Chester

University of Sheffield

Zulassung

Bar

  • England and Wales

Berufliche Aktivitäten

  • Law Society
  • Recommended (Legal 500 2018 Equity Capital Markets)